title: Replication and endoreplication in developing megakaryocytes in vitro.
abstract: To study the relation in time between replication and endoreplication and the relation between appearance of platelet-specific proteins and endoreplication in maturing megakaryocytes, peripheral blood mononuclear cells highly enriched in hematopoietic progenitors were cultured in liquid cultures and plasma clots in the presence of either interleukin-3 (IL-3) and stem cell factor (SCF) or medium conditioned by blood mononuclear cells stimulated by phytohemagglutinin (PHA). In plasma clots, megakaryocytic (MK) colonies appeared first on day 5 and reached a maximum by day 8, whereas the number of cells per colony increased until day 10, indicating that there was a single wave of MK colony formation. In liquid cultures, the first immunologically recognizable megakaryocytes appeared on day 5 and expressed GPIIb/IIIa and thrombospondin only, but all other platelet-specific protein markers appeared within 24 hours. Replating cells from liquid medium into plasma clots showed that 92 +/- 8% of day 6 GPIIb/IIIa-positive cells are capable of replicating. Their replicative potential decreased with age, however, so that between days 6 and 11, a linear correlation was noted between the logarithm of the percentage of megakaryocytes with replicative capacity and their age in culture. Replication ceased completely after day 10. In the presence of IL-3, polyploid megakaryocytes appeared at the same time that GPIIb/IIIa was expressed, and the megakaryocyte distribution into ploidy classes remained unchanged until day 20. In the presence of PHA-leukocyte conditioned medium (PHA-LCM), ploidy of megakaryocytes was shifted toward higher classes after day 6, and the process of endoreplication was completed by day 10. No changes in ploidy distribution were noted between days 10 and 20. These findings indicate that in the cohort of megakaryocytes derived from colony-forming units-megakaryocyte (CFU-MK), endoreplication can occur at an early stage of development, proceeds synchronously with replication, and is completed before the megakaryocytes exhaust their replicative potential.
authors.affiliation: Department of Medicine, H. H. McGuire Department of Veterans Affairs Medical Center, Richmond, VA 23249.
authors.forename: P
authors.initials: P
authors.lastname: Angchaisuksiri
authors.forename: P L
authors.initials: PL
authors.lastname: Carlson
authors.forename: E B
authors.initials: EB
authors.lastname: Day
authors.forename: E N
authors.initials: EN
authors.lastname: Dessypris
mesh_terms: D000328:Adult; D002455:Cell Division; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000166:cytology; D008533:Megakaryocytes / Q000166:cytology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D010980:Platelet Membrane Glycoproteins / Q000032:analysis; D011003:Ploidies; D019089:Stem Cell Factor; D013997:Time Factors
chemical_list: D017077:Culture Media, Conditioned; D016298:Hematopoietic Cell Growth Factors; D007377:Interleukin-3; D010835:Phytohemagglutinins; D010980:Platelet Membrane Glycoproteins; D019089:Stem Cell Factor